 |
인쇄하기
취소
|
New cancer pill gives hope and strategy
Pfizer Korea’s just-launched drug Xalkori (crizotinib), the first new medicine for deadly lung cancer, proves the value of precisely targeting rare diseases linked to gene variants, cancer specialists said.
Pfizer Korea held a news briefing Friday to discuss the implications of the new drug.
“This is a paradigm shift,” Dr. Kim Dong-wan., a professor Seoul National University and cancer re...
Pfizer Korea held a news briefing Friday to discuss the implications of the new drug.
“This is a paradigm shift,” Dr. Kim Dong-wan., a professor Seoul National University and cancer re...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.